CSBR icon

Champions Oncology

31 hedge funds and large institutions have $42.5M invested in Champions Oncology in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-3
Holders Change %
-8.82%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
4
Increased
8
Reduced
7
Closed
7
Calls
$317K
Puts
Net Calls
+$317K
Net Calls Change
-$52K
Name Holding Trade Value Shares
Change
Shares
Change %
Lazard Asset Management
26
Lazard Asset Management
New York
$9K +$9K +1,349 New
Osaic Holdings
27
Osaic Holdings
Arizona
$857
SS
28
SBI Securities
Japan
$192 +$74 +10 +63%
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
$81
GC
30
Garde Capital
Washington
$8
EI
31
EAM Investors
California
-$694K -79,987 Closed
Goldman Sachs
32
Goldman Sachs
New York
-$201K -23,129 Closed
Citadel Advisors
33
Citadel Advisors
Florida
-$199K -22,902 Closed
OAC
34
OMERS Administration Corp
Ontario, Canada
-$92.9K -10,700 Closed
Citigroup
35
Citigroup
New York
-$42.7K -4,915 Closed
UBS Group
36
UBS Group
Switzerland
-$4.59K -529 Closed
TRCT
37
Tower Research Capital (TRC)
New York
-$4.35K -501 Closed